Healthcare -
Biotechnology - NASDAQ - US
$ 0.9163
-12.7 %
$ 118 M
Market Cap
-0.29
P/E
HUMAW - LONG-TERM DEBT
Long-term Debt HUMAW - Humacyte, Inc.
54.9 M
LAST VALUE
5.68%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR